Exploring the people, challenges, and opportunities impacting the global #medtech regulatory, reimbursement and policy communities. Likes,RTs,etc ≠ endorsement.
- Tweets3.3K
- Following142
- Followers262
- Likes8.4K
ALT .@MedTechStrat, @Market_Pathways, and the #medtech community are already making plans for Boston. Come meet some members of our team at Booth #1136 at #MedTechCon:
ALT Some people leave a mark on an industry that lasts far beyond their lifetime. We mourn the loss of our colleague, friend, and co-founder @DCassak. His kindness and legacy will not be forgotten: https://bit.ly/3TROZpv
ALT CDRH Director Michelle Tarver, MD, PhD, joins @Filmoreorless of @Market_Pathways at #InnovationSummit this year for an opening keynote & fireside chat on TAP, early feasibility studies, FDA-CMS alignment, #AI, cybersecurity & more. Bring your questions: https://bit.ly/4h7JsTs
ALT Stay closer to what’s shaping the #medtech industry. 📖 Claim a free print issue of @MedTechStrat or @Market_Pathways and get expert insight and analysis delivered straight to you. Claim your free issue: https://bit.ly/4xw0rpv
ALT A person in a lab coat interacts with a digital interface displaying hexagonal icons and technological symbols. The overlay text reads, "Discussion paper and request for feedback: Considerations for the Regulation of Generative AI-Enabled Medical Devices." The FDA logo is visible in the corner.
ALT Halfway through 2026, 1 resource stands above the rest. Pathways' Document Depot is our most viewed resource of the year, helping #medtech professionals stay on top of global #regulatory updates: https://bit.ly/3TFQ17x
ALT 890+ pages that could impact #medtech. @CMSGov finalized NTAP changes with a 2-year transition for Breakthrough Devices. Download the nearly 900-page FY2027 IPPS rule PDF: https://bit.ly/4zj1eeP
ALT 2029 may seem far off, but the MDR/IVDR transition continues to reshape the #medtech landscape. See how manufacturers and #notifiedbodies are tracking progress across Europe. Does this reflect what you're seeing?
ALT The smartest people in #medtech stay ahead of change. Market Pathways delivers expert insights on policy, regulation, #reimbursement, and market access so you can make better decisions. Subscribe today: https://bit.ly/4biPNt5
ALT The smartest #medtech conversations happen here. Explore the @Market_Pathways podcast for expert insights on policy, strategy, and #reimbursement. Listen: https://bit.ly/4wy078v
ALT The next chapter of #MedTech regulation is already taking shape. Hear @Filmoreorless's take on MDUFA VI and the changes worth watching. July 24 at 11 AM ET. Mark your attendance here: https://bit.ly/4gBdQqH
ALT Struggling with #MDR/IVDR classification? The updated EU Borderline & Classification Manual (v5, April 2026) offers key guidance. Explore it and access more in Pathways’ Document Depot: https://bit.ly/4dZDRyB
